SIREN : 798033817
LABOGENA DNA is a French company founded 12 years ago, specialized in the sector Activités de soutien à la production animale. Based in NOYAL-SUR-VILAINE (35530), this company of category PME shows in 2024 a revenue of 7.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-08-08
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
Aucun signal de fragilité majeur : rentabilité positive et structure financière équilibrée.
In summary, LABOGENA DNA combines a growing business with positive profitability. Its financial structure is solid, with debt well contained relative to its sector.
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7 537 425 € | 5 912 064 € | 5 681 518 € | 5 473 738 € | 4 765 111 € | 4 040 062 € | N/C | 4 276 666 € |
| Net income | 170 135 € | 70 443 € | 543 611 € | 819 983 € | 676 206 € | 122 380 € | -246 881 € | -646 648 € |
| EBITDA | 403 619 € | 626 835 € | 656 524 € | 1 007 107 € | 1 018 168 € | 355 375 € | N/C | -222 861 € |
| Net margin | 2.3% | 1.2% | 9.6% | 15.0% | 14.2% | 3.0% | N/C | -15.1% |
In 2024, LABOGENA DNA achieves revenue of 7.5 M€. Over the period 2020-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +12.1%. Vs 2023, growth of +27% (5.9 M€ -> 7.5 M€). After deducting consumption (3.3 M€), gross margin stands at 4.2 M€, i.e. a rate of 56%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 404 k€, representing 5.4% of revenue. Warning negative scissor effect: despite revenue change (+27%), EBITDA varies by -36%, reducing margin by 5.2 pts. This reflects costs rising faster than revenue. This ratio is slightly less favorable than the sector median (5.7%). Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 170 k€, i.e. 2.3% of revenue. This profit can be retained or distributed to shareholders.
7 537 425 €
4 229 893 €
403 619 €
105 649 €
170 135 €
5.4%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. Compared with its sector, this ratio places the company among the best positioned (sector median: 11.3%). Financial autonomy (= Equity / Total assets x 100) reaches 67%. Compared with its sector, this ratio places the company among the best positioned (sector median: 33.9%). Cash flow represents 5.0% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This ratio is slightly less favorable than the sector median (7.4%).
0.0%
67.46%
5.02%
0.0
45.1%
In 2024, the debt ratio of LABOGENA DNA (0.0%) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2024, the financial autonomy of LABOGENA DNA (67.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2024, the repayment capacity of LABOGENA DNA (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 1.78. This ratio is slightly less favorable than the sector median (1.9). The interest coverage ratio (= EBIT / Interest expenses) is 1.2x. This ratio is more favorable than the sector median (0.2x).
1.78
1.18
In 2024, the liquidity ratio of LABOGENA DNA (1.78) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of LABOGENA DNA (1.2x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 49 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 57 days. Favorable situation: supplier credit is longer than customer credit by 8 days. Inventory turnover is 35 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 81 days of revenue, i.e. 1.7 M€ to permanently finance. Between 2021 and 2024, WCR improved by 21 days of revenue, freeing up cash.
1 685 745 €
49 j
57 j
35 j
81 j
Based on 60 transactions of similar company sales
(all years),
the value of LABOGENA DNA is estimated at
1 365 707 €
(range 469 978€ - 2 537 182€).
With an EBITDA of 403 619€, the sector multiple of 2.4x is applied.
The price/revenue ratio is 0.37x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 60 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare LABOGENA DNA with other companies in the same sector:
Voir toutes les statistiques du secteur Activités de soutien à la production animale
Largest companies by revenue in the sector Activités de soutien à la production animale:
Largest companies by revenue in the department Ille-et-Vilaine:
The revenue of LABOGENA DNA in 2024 is 7.5 M€.
Yes, LABOGENA DNA generated a net profit of 170 k€ in 2024.
The headquarters of LABOGENA DNA is located in NOYAL-SUR-VILAINE (35530), in the department Ille-et-Vilaine.
The tax return of LABOGENA DNA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
LABOGENA DNA operates in the sector Activités de soutien à la production animale (NAF code 01.62Z). See the 'Sector positioning' section above to compare the company with its competitors.